Skip to main content
SpringerLink
Log in

Nanomedicine: A Hyper-expectation and Dawning Realisation?

  • Chapter
  • First Online:
Nanomedicine

Part of the book series: Nanostructure Science and Technology ((NST))

  • 1699 Accesses

Abstract

As a society, this generation more so than any other, has grown accustomed to rapid technological advancement within condensed periods of time. This mentality has escalated to the degree that such advancement is expected in increasing instalments with the passage of time. Nanomedicine is not exempt from this expectation nor has it disappointed thus far as any review of the literature will demonstrate. There is however a significant separation between the hyper-expectation of the research concepts of nanomedicine and the reality of applying such revolutionary techniques and therapies within a clinical setting. This generation, due to the phenomenal pace of research and development, is in the unique position to be permitted to witness both the development of the concept and its assimilation into medicine. In this way, both hyper-expectation and dawning realisation stand side by side to create this unique and highly dynamic time of the implementation of nanomedicine to reality of practiced clinical medicine.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Booker KM (2006) Forbidden planet. In: Alternative America: science fiction film and American culture. Praegar Publishers, Westport, pp 43–49

    Google Scholar 

  2. McCurdy HE (2006) Observations on the robotic versus human issue in spaceflight. In: Dick SJ, Launius RD (eds) Critical issues in the history of spaceflight. Government Printing Office, Washington, pp 77–107

    Google Scholar 

  3. Brock DC (2006) Understanding Moore’s law: four decades of innovation. CHF Publications, Philadelphia

    Google Scholar 

  4. Culver HR, Daily AM, Khademhosseini A, Peppas NA (2014) Intelligent recognitive systems in nanomedicine. Curr Opin Chem Eng 4:105–113

    Google Scholar 

  5. Fattal E, Tsapis N (2014) Nanomedicine technology: current achievements and new trends. Clin Transl Imaging 2(1):77–87

    Google Scholar 

  6. Tong S, Fine EJ, Lin Y, Cradick TJ, Bao G (2014) Nanomedicine: tiny particles and machines give huge gains. Ann Biomed Eng 42(2):243–259

    Google Scholar 

  7. Wiesing U, Clausen J (2014) The clinical research of nanomedicine: a new ethical challenge? Nanoethics 8(1):19–28

    Google Scholar 

  8. Roco MC (2005) International perspective on government nanotechnology funding in 2005. J Nanopart Res 7(6):1–9

    Google Scholar 

  9. NNI (2013) Coordination of the NNI. http://www.nano.gov/about-nni/what/coordination. Accessed 27 June 2013

  10. Sargent JF (2013) The national nanotechnology initiative: overview, reauthorization and appropriation issues. http://www.fas.org/sgp/crs/misc/RL34401.pdf. Accessed 27 June 2013

  11. National Cancer Institute (2010) Cancer nanotechnology plan. http://nano.cancer.gov/objects/pdfs/CaNanoPlan.pdf. Accessed 27 June 2013

  12. Hullmann A (2006) Who is winning the global nanorace? Nat Nanotechnol 1:81–83

    CAS  Google Scholar 

  13. Lux Research (2004) Sizing nanotechnology’s value chain. http://www.altassets.net/pdfs/sizingnanotechnologysvaluechain.pdf. Accessed 29 June 2013

  14. Roco MC (2010) The long view of nanotechnology development: the national nanotechnology initiative at ten years. In: Roco MC, Mirkin C, Hersam M (eds) Nanotechnology research directions for societal needs in 2020. Springer, New York

    Google Scholar 

  15. Song H, Kim Y, Jang YH, Jeong H, Reed MA, Lee T (2009) Observation of molecular orbital gating. Nature 462(7276):1039–1043

    CAS  Google Scholar 

  16. Mansour TE (2002) Chemotherapeutic targets in parasites: contemporary strategies. Cambridge University Press, Cambridge

    Google Scholar 

  17. Mehra J (1994) The beat of a different drum: the life and science of Richard Feynman. Clarendon, Oxford

    Google Scholar 

  18. Drexler KE (1986) Engines of creation, 1st edn. Anchor Press/Doubleday, Garden City

    Google Scholar 

  19. Kaiser M, Maasen S, Kurath M (2010) Governing future technologies: nanotechnology and the rise of an assessment regime. Springer, Dordrecht

    Google Scholar 

  20. Huxley A (2007) Brave new world, 2nd edn. Vintage, London

    Google Scholar 

  21. Crichton M (2002) Prey. Harper Collins, New York

    Google Scholar 

  22. Gee JP (2003) What video games have to teach us about learning and literacy. Palgrave Macmillan, New York

    Google Scholar 

  23. Lutz W, Sanderson W, Scherbov S (2008) The coming acceleration of global population ageing. Nature 451:716–719

    CAS  Google Scholar 

  24. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002) Cancer. In: Molecular biology of the cell, 4th edn. Garland Science, New York, pp 1313–1362

    Google Scholar 

  25. Murray SA, Kendall M, Boyd K, Sheikh A (2005) Illness trajectories and palliative care. Br Med J 330:1001–1011

    Google Scholar 

  26. Giacca M (2010) Clinical applications of gene therapy. In: Gene therapy. Springer, New York, pp 139–282

    Google Scholar 

  27. Slavicek LC, Mitchell GJ, Matray JI (2005) The great wall of China. Chelsea House Publishers, New York, NY, USA

    Google Scholar 

  28. De Grey ADNJ, Rae M (2007) Ending aging: the rejuvenation breakthroughs that could reverse human aging in our lifetime. St. Martin’s Press, New York

    Google Scholar 

  29. Androutsos G, Diamantis A, Vladimiros L (2008) The first left transplant for the treatment of a cancer by Saints Cosmas and Damian. J BUON 13(2):297–304

    CAS  Google Scholar 

  30. Wong BW, Rahmani M, Rexai N, McManus BM (2005) Progress in heart transplantation. Cardiovasc Pathol 14(4):176–180

    Google Scholar 

  31. Toledo-Pereyra LH (2010) Heart transplantation. J Invest Surg 23:1–5

    Google Scholar 

  32. Murray JE (1982) Reflections on the first successful kidney transplantation. World J Surg 6(3):372–376

    CAS  Google Scholar 

  33. NHSBT (2011) Statistics: transplants save lives. http://www.uktransplant.org.uk/ukt/statistics/statistics.jsp. Accessed 27 June 2013

  34. Morris PJ (2004) Transplantation – a medical miracle of the 20th century. N Engl J Med 351(26):2678–2680

    CAS  Google Scholar 

  35. Cruickshank CND, Cooper JR, Hooper C (1960) The cultivation of adult epidermis. J Invest Dermatol 34:339–342

    CAS  Google Scholar 

  36. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB (2006) Tissue-engineered autologous bladders for patients needing cystoplasty. The Lancet 367(9518):1241–1246

    Google Scholar 

  37. Raya-Rivera A, Esquiliano DR, Yoo JJ, Lopez-Bayghen E, Soker S, Atala A (2011) Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. The Lancet 377(9772):1175–1182

    Google Scholar 

  38. Ott HC, Matthiesen TS, Goh S, Black LD, Kren SM, Netoff TI, Taylor DA (2008) Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med 14(2):213–221

    CAS  Google Scholar 

  39. Lee W, Pinckney J, Lee V, Lee J, Fischer K, Polio S, Park J, Yoo S (2009) Three-dimensional bioprinting of rat embryonic neural cells. Neuroreport 20(8):798–803

    Google Scholar 

  40. Takebe T, Sekine K, Enomura M, Koike H, Kimura M, Ogaeri T, Zhang RR, Ueno Y, Zheng YW, Koike N, Aoyama S, Adachi Y, Taniguchi H (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature. doi:10.1038/nature12271

    Google Scholar 

  41. Wu MC (2011) Optoelectronic tweezers. Nat Photonics 5(6):322–324

    CAS  Google Scholar 

  42. Jain KK (2008) The handbook of nanomedicine. Humana Press/Springer, Totowa

    Google Scholar 

  43. Church D, Elsayed S, Reid O, Winston B, Lindsay R (2006) Burn wound infections. Clin Microbiol Rev 19(2):403–434

    Google Scholar 

  44. Buncke HJ Jr (2000) Microvascular hand surgery – transplants and replants – over the past 25 years. J Hand Surg 25(3):415–428

    Google Scholar 

  45. Hamzelou J (2011) World’s first double leg transplant performed in Spain. N Sci 2821:4

    Google Scholar 

  46. Barret JP, Gavaldà J, Bueno J, Nuvials X, Pont T, Masnou N, Colomina MJ, Serracanta J, Arno A, Huguet P, Collado JM, Salamero P, Moreno C, Deulofeu R, Martínez-Ibáñez V (2011) Full face transplant: the first case report. Ann Surg 254(2):252–256

    Google Scholar 

  47. Spurgeon B (2005) Surgeons pleased with patient’s progress after face transplant. Br Med J (Clin Res Ed) 331(7529):1359

    Google Scholar 

  48. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493–506

    CAS  Google Scholar 

  49. Obataya I, Nankamura C, Han SW, Nakamura N, Miyake J (2005) Nanoscale operation of a living cell using an atomic force microscope with a nanoneedle. Nano Lett 5:27–30

    CAS  Google Scholar 

  50. Beard JD, Burbridge DJ, Moskalenko AV, Dudko O, Yarova PL, Smirnov SV, Gordeev SN (2009) An atomic force microscope nanoscalpel for nanolithography and biological applications. Nanotechnology 20:1–10

    Google Scholar 

  51. Lindström UM, Chandrasekaran RA, Orbai L, Helquist SA, Miller GP, Oroudjev E, Hansma HG, Kool ET (2002) Artificial human telomeres from DNA nanocircle templates. Proc Natl Acad Sci USA 99(25):15953–15958

    Google Scholar 

  52. Abad M, Mosteiro L, Pantoja C, Canamero M, Rayon T, Ors I, Grana O, Megias D, Dominguez O, Martinez D, Manzanares M, Ortega S, Serrano M (2013) Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature. doi:10.1038/nature12586

    Google Scholar 

  53. Jungebluth P, Alici E, Baiguera S, Le Blanc K, Blomberg P, Bozoky B, Crowley C, Einarsson O, Grinnemo KH, Gudbjartsson T, Le Guyader S, Henriksson G, Hermanson O, Juto JE, Leidner B, Lilja T, Liska J, Luedde T, Lundin V, Moll G, Nilsson B, Roderburg C, Stromblad S, Sutlu T, Teixeira AI, Watz E, Seifalian A, Macchiarini P (2011) Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet 378:1997–2004

    CAS  Google Scholar 

  54. Roach M (2003) Stiff: the curious lives of human cadavers. Viking, London

    Google Scholar 

  55. Marshal E (1999) Gene therapy death prompts review of adenovirus vector. Science 286:2244–2245

    Google Scholar 

  56. Frankel MS (2000) In search of stem policy. Science 287:1397

    CAS  Google Scholar 

  57. Zhu Y, Wang A, Shen W, Patel S, Zhang P, Young WL, Li S (2010) Nanofibrous patches for spinal cord regeneration. Adv Funct Mater 20:1433–1440

    CAS  Google Scholar 

  58. Göritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisén J (2011) A pericyte origin of spinal cord scar tissue. Science 333:238–242

    Google Scholar 

  59. De Silva MN, Almeida MV, Goldberg JL (2007) Developing super-paramagnetic nanoparticles for central nervous system axon regeneration. In: Technical proceedings of the 2007 NSTI nanotechnology conference and trade show, vol 2, Taylor & Francis, USA, pp 791–794

    Google Scholar 

  60. Mayor S (2010) First patient enters trial to test safety of stem cells in spinal injury. Br Med J 341:c5724

    Google Scholar 

  61. Wise J (2010) Stroke patients take part in “milestone” UK trial of stem cell therapy. Br Med J 341:c6574

    Google Scholar 

  62. ReNeuron Group (2011) ReNeuron receives DSMB clearance to progress to higher dose in ReN001 stem cell trial for stroke. http://www.reneuron.com/news/249. Accessed 29 June 2013

  63. Nimmo J (2013) ReNeuron sticks to timeline after impressive progress. http://www.proactiveinvestors.co.uk/companies/news/61053/reneuron-sticks-to-timeline-after-impressive-progress-61053.html. Accessed 16 Sept 2013

  64. Stein LD (2004) End of the beginning. Nature 431:915–916

    CAS  Google Scholar 

  65. Spencer N, Katsnelson A, Loman N, Hadfield J (2010) Human genome: genomes by the thousand. Nature 467(7319):1026–1027

    Google Scholar 

  66. Nelson RF (1968) We froze the first man.Dell publishing company (now Bantham-Dell publishing group & member of Random house), New York, NY, USA

    Google Scholar 

  67. Shoffstall G (2010) Freeze, wait, reanimate: cryonic suspension and science fiction. Bull Sci Technol 30(4):285–297

    Google Scholar 

  68. Best BP (2008) Scientific justification of cryonics practice. Rejuvenation Res 11(2):493–503

    Google Scholar 

  69. Fahy GM, Wowk B, Pagotan R, Chang A, Phan J, Thomson B, Phan L (2009) Physical and biological aspects of renal vitrification. Organogenesis 5(3):167–175

    Google Scholar 

  70. Leduc PR, Wong MS, Ferreira PM, Groff RE, Haslinger K, Koonce MP, Lee WY, Love JC, McCammon JA, Monteiro-Riviere NA, Rotello VM, Rubloff GW, Westervelt R, Yoda M (2007) Towards an in vivo biologically inspired nanofactory. Nat Nanotechnol 2(1):3–7

    CAS  Google Scholar 

  71. Gibson DG, Glass JI, Lartigue C, Noskov VN, Chuang RY, Algire MA, Benders GA, Montague MG, Ma L, Moodie MM, Merryman C, Vashee S, Krishnakumar R, Assasad-Garcia N, Andrews-Pfannkoch C, Denisova EA, Young L, Qi ZQ, Segall-Shapiro TH, Calvey CH, Parmar PP, Hutchison CA, Smith HO, Venter C (2010) Creation of a bacterial cell controlled by a chemically synthesized genome. Science 329:52–56

    CAS  Google Scholar 

  72. Douglas T, Young M (1998) Host-guest encapsulation of materials by assembled virus protein cages. Nature 393:152–155

    CAS  Google Scholar 

  73. Edelstein M (2011) Gene therapy trials worldwide provided by the journal of gene medicine. http://www.wiley.com/legacy/wileychi/genmed/clinical. Accessed 29 June 2013

  74. Cannet A (2013) Carmat gets approval to test artificial heart in four countries, Reuters. http://www.reuters.com/article/2013/05/14/us-carmat-artificialheart-idUSBRE94D0KL20130514. Accessed 15 July 2013

  75. Grimme M, Gourgues JE, Carpentier A, Wartelle C (2009) Implantable one-piece heart prosthesis. European Patent WO2009112662 A2

    Google Scholar 

  76. Wilson BS, Finley CC, Lawson DT, Wolford RD, Eddington DK, Rabinowitz WM (1991) Better speech recognition with cochlear implants. Nature 352:236–238

    CAS  Google Scholar 

  77. Zrenner E (2002) Will retinal implants restore vision? Science 295(5557):1022–1025

    CAS  Google Scholar 

  78. Dobelle WH (2000) Artificial vision for the blind by connecting a television camera to the visual cortex. ASAIO J 46:3–9

    CAS  Google Scholar 

  79. Bock DD, Lee WCA, Kerlin AM, Andermann ML, Hood G, Wetzel AW, Yurgenson S, Soucy ER, Kim HS, Reid RC (2011) Network anatomy and in vivo physiology of visual cortial neurons. Nature 471:177–182

    CAS  Google Scholar 

  80. Joshi J, Zhang J, Wang C, Hsu CC, Parker AC, Zhou C, Ravishankar U (2011) A biomimetic fabricated carbon nanotube synapse for prosthetic applications, IEEE/NIH 5th Life Science Systems and Applications Workshop (LiSSA), pp 139–142. National Institutes of Health (NIH)Campus, Bethesda, Maryland, USA

    Google Scholar 

  81. Berger TW, Granacki JJ, Marmarelis VZ, Sheu BJ, Tanguay AR Jr (2003) Brain-implantable biomimetic electronics as neural prosthetics, Engineering in Medicine and Biology Society, 2003. Proceedings of the 25th Annual International Conference of the IEEE, vol.2, no., pp.1956–1959 Vol.2, 17–21 Sept. 2003, Cancun, Mexico

    Google Scholar 

  82. Berger TW, Hampson RE, Song D, Goonawardena A, Marmarelis VZ, Deadwyler SA (2011) A cortical neural prosthesis for restoring and enhancing memory. J Neural Eng 8(4):046017

    Google Scholar 

  83. Hochberg LR, Serruya MD, Friehs GM, Mukand JA, Saleh M, Caplan AH, Branner A, Chen D, Penn RD, Donoghue JP (2006) Neuronal ensemble control of prosthetic devices by a human with tetraplegia. Nature 442:165–171

    Google Scholar 

  84. McIntyre CC, Savasta M, Kerkerian-Le Goff L, Vitek JL (2004) Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both. Clin Neurophysiol 115:1239–1248

    Google Scholar 

  85. Schiff ND, Giacino JT, Kalmar K, Victor JD, Baker K, Gerber M, Fritz B, Eisenberg B, O’Connor J, Kobylarz EJ, Farris S, Machado A, McCagg C, Plum F, Fins JJ, Rexai AR (2007) Behavioural improvements with thalamic stimulation after severe traumatic brain injury. Nature 448(7153):600–603

    CAS  Google Scholar 

  86. Coenen VA, Schlaepfer TE, Maedler B, Panksepp J (2011) Cross-species affective functions of the medial forebrain bundle-implications for the treatment of affective pain and depression in humans. Neurosci Behav Res 35(9):1971–1981

    Google Scholar 

  87. Sesack SR, Carr DB (2002) Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia. Physiol Behav 77:513–517

    CAS  Google Scholar 

  88. Moravec H (1998) When will computer hardware match the human brain? J Evol Technol http://www.jetpress.org/volume1/moravec.htm. Accessed 27 June 2013

  89. ASCI (2010) 100 teraFLOPS dedicated to capability computing. https://asc.llnl.gov/computing_resources/purple . Accessed 29 June 2013

  90. Sandberg A, Bostrom N (2008) Whole brain emulation: a roadmap. Future of Humanity Institute, Oxford University. http://www.fhi.ox.ac.uk/wp-content/uploads/brain-emulation-roadmap-report1.pdf. Accessed 29 June 2013

  91. Williams GC (1999) The Tithonus error in modern gerontology. Q Rev Biol 74(4):405–415

    CAS  Google Scholar 

  92. Hurst SA, Mauron A (2003) Assisted suicide and euthanasia in Switzerland: allowing a role for non-physicians. Br Med J 326:271–273

    Google Scholar 

  93. BBC (2013) Terry Pratchett: choosing to die. http://www.bbc.co.uk/programmes/b0120dxp. Accessed 17 Sept 2013

  94. DESA (2010) World population aging 2009, United Nations. http://www.un.org/esa/population/publications/WPA2009/WPA2009-report.pdf . Accessed 27 June 2013

  95. Bongaarts J (2009) Human population growth and the demographic transition. Phil Trans R Soc B 364:2985–2990

    Google Scholar 

  96. Lewis MJ (2007) Medicine and care of the dying: a modern history. Oxford University Press, Oxford

    Google Scholar 

  97. Connell PP, Hellman S (2009) Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res 69:383–392

    CAS  Google Scholar 

  98. Devita VT Jr, Chu E (2008) A history of cancer chemotherapy. Cancer Res 68:8643–8653

    CAS  Google Scholar 

  99. Hare R (1982) New light on the history of penicillin. Med Hist 26:1–24

    CAS  Google Scholar 

  100. Nesse RM (2000) Is depression an adaption? Arch Gen Psychiatry 57(1):14–20

    CAS  Google Scholar 

  101. Petronis A (2004) The origin of schizophrenia: genetic thesis, epigenetic antithesis, and resolving synthesis. Biol Psychiatry 55:965–970

    CAS  Google Scholar 

  102. Laćan G, De Salles AA, Gorgulho AA, Krahl SE, Frighetto L, Behnke EJ, Melega WP (2008) Modulation of food intake following deep brain stimulation of the ventromedial hypothalamus in the vervet monkey. Laboratory investigation. J Neurosurg 108(2):336–342

    Google Scholar 

  103. Henderson MB, Green AI, Bradford PS, Chau DT, Roberts DW, Leiter JC (2010) Deep brain stimulation of the nucleus accumbens reduces alcohol intake in alcohol-preferring rats. Neurosurg Focus 29(2):E12

    Google Scholar 

  104. Burgess A (1962) A clockwork orange. William Heinemann, London

    Google Scholar 

  105. Koestler A (1967) The ghost in the machine. Hutchinson, London

    Google Scholar 

  106. Hulkower R (2011) From sacrilege to privilege: the tale of body procurement for anatomical dissection in the United States. Einstein J Biol Med 27(1):23–26

    Google Scholar 

  107. Shildrick M, McKeever P, Abbey S, Poole J, Ross H (2009) Troubling dimensions of heart transplantation. Med Humanit 35:35–38

    CAS  Google Scholar 

  108. Sanner MA (2003) Transplant recipients’ conceptions of three key phenomena in transplantation: the organ donation, the organ donor and the organ transplant. Clin Transplant 17(4):391–400

    Google Scholar 

  109. Kemph JP (1966) Renal failure, artificial kidney and kidney transplant. Am J Psychiatry 122:1270–1274

    CAS  Google Scholar 

  110. Young EJ, Aceti M, Griggs EM, Fuchs RA, Zigmond Z, Rumbaugh G, Miller CA (2013) Selective, retrieval-independent disruption of methamphetamine-associated memory by actin depolymerization. Biol Psychiatry. doi:10.1016/j.biopsych.2013.07.036

    Google Scholar 

  111. Shirow M (1995) Ghost in the shell. Dark Horse Comics, Milwaukie

    Google Scholar 

  112. Lerner J, Wulf J (2007) Innovation and incentives: evidence from corporate R&D. Rev Econ Stat 89:634–644

    Google Scholar 

  113. Agin D (2007) Junk science: an overdue indictment of government, industry, and faith groups that twist science for their own gain. St Martin’s Press, New York

    Google Scholar 

  114. Schön JH, Meng H, Bao Z (2001) Self-assembling monolayer organic field-effect transistors. Nature 413:713–716

    Google Scholar 

  115. Beasley MR, Kroemer H, Kogelnik H, Monroe D, Datta S (2002) Report of the investigation committee on the possibility of scientific misconduct in the work of Hendrik Schön and coauthors. http://publish.aps.org/reports/lucentrep.pdf . Accessed 27 June 2013

  116. Schön JH (2003) Retraction. Nature 422(6927):92–93

    Google Scholar 

  117. Schön JH (2002) Retraction. Science 298(5595):961

    Google Scholar 

  118. Reich ES (2010) Plastic fantastic: how the biggest fraud in physics shook the scientific world. Palgrave Macmillan, Basingstoke, Hampshire, UK

    Google Scholar 

  119. Van Noorden R (2011) Science publishing: the trouble with retractions. Nature 478(7367):26–28

    Google Scholar 

  120. Borzelleca JF (2000) Paracelsus: herald of modern toxicology. Toxicol Sci 53(1):2–4

    CAS  Google Scholar 

  121. Oberdörster G, Oberdörster E, Oberdörster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839

    Google Scholar 

  122. FDA (2012a) Guidance for industry: assessing the effects of significant manufacturing process changes, including emerging technologies, on the safety and regulatory status of food ingredients and food contact substances, including food ingredients that are color additives. http://www.fda.gov/downloads/Cosmetics/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/UCM300927.pdf. Accessed 18 Sept 2013

  123. FDA (2012b) Guidance for industry: safety of nanomaterials in cosmetic products. http://www.fda.gov/downloads/Cosmetics/GuidanceComplianceRegulatoryInformation/GuidanceDocuments/UCM300932.pdf. Accessed 18 Sept 2013

  124. Tyner K, Sadrieh N (2011) Considerations when submitting nanotherapeutics to FDA/CDER for regulatory review. In: McNeil SE (ed) Characterization of nanoparticles intended for drug delivery. Humana Press, New York

    Google Scholar 

  125. Hamburg MA (2012) Science and regulation. FDA’s approach to regulation of products of nanotechnology. Science 336(6079):299–300

    CAS  Google Scholar 

  126. REACH (2008) Regulatory aspects of nanomaterials 2008. http://ec.europa.eu/nanotechnology/pdf/comm_2008_0366_en.pdf. Accessed 29 June 2013

  127. SCENIHR (2010) Scientific basis for the definition of the term “Nanomaterial”. http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_o_030.pdf. Accessed 29 June 2013

  128. Brouwer N, Weda M, Van Riet-Nales D, De Kaste D (2010) Nanopharmaceuticals: implications for the European pharmacopoeia. Pharmeuropa 22:5–7

    Google Scholar 

  129. EC (2013a) Consultation on the modification of the REACH Annexes on Nanomaterials. http://ec.europa.eu/environment/consultations/nanomaterials_2013_en.htm. Accessed 18 Sept 2013

  130. EC (2013b) Nanotechnology. http://ec.europa.eu/nanotechnology/index_en.html. Accessed 18 Sept 2013

  131. Nowack B, Krug HF, Height M (2011) 120 years of nanosilver history: implications for policy makers. Environ Sci Technol 45:1177–1183

    CAS  Google Scholar 

  132. Braydich-Stolle L, Hussain S, Schlager J, Hofmann MC (2005) In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88(2):412–419

    CAS  Google Scholar 

  133. EFSA (2008) Inability to assess the safety of a silver hydrosol added for nutritional purposes as a source of silver in food supplements and the bioavailability of silver from this source based on the supporting dossier. EFSA J http://www.efsa.europa.eu/en/scdocs/doc/ans_ej884_Silver_Hydrosol_st_en.pdf?ssbinary=true. Accessed 29 June 2013

  134. EC (2009) Commission Regulation (EC) No 1170/2009. Official Journal of the European Union. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri = OJ:L:2009:314:0036:0042:EN:PDF. Accessed 18 Sept 2013

Download references

Author information

Authors and Affiliations

  1. Universitat Autònoma de Barcelona, Barcelona, Spain

    Ferdia Bates

Authors
  1. Ferdia Bates
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ferdia Bates .

Editor information

Editors and Affiliations

  1. Centre for Biomedical Engineering, School of Engineering, Cranfield University, Bedfordshire, Bedfordshire, United Kingdom

    Yi Ge

  2. School of Materials Science & Engineering, Jiangsu University, Zhenjiang, China

    Songjun Li

  3. Advanced Biomaterials and Tissue Engineering Centre, College of Life Science and Technology, Huanzhong University of Science and Technology, Wuhan, China

    Shenqi Wang

  4. Biomimesis, Melton Mowbray, Leicestershire, United Kingdom

    Richard Moore

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bates, F. (2014). Nanomedicine: A Hyper-expectation and Dawning Realisation?. In: Ge, Y., Li, S., Wang, S., Moore, R. (eds) Nanomedicine. Nanostructure Science and Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2140-5_13

Download citation

Publish with us

Policies and ethics

Search

Navigation